LITTLE SILVER, N.J.,
May 16, 2018 /PRNewswire/ -- Additive
Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and
ankle devices, today announced that is has received FDA 510(k)
clearance for its Patient Specific 3D Printed Bone Segments, to
address internal bone fixation in the ankle and foot.
According to Greg Kowalczyk,
President of Additive Orthopaedics, "This is a tremendous milestone
for orthopaedics and the obvious trend towards patient specific 3D
printed implants. In cases of implant revision, limb salvage,
and trauma, often there are no clinically available devices to
address the patient's condition. This is where 3D printed
patient specific implants are making significant clinical
impacts."
According to Brian McLaughlin, VP
of Engineering and Operations, "Our lattice structures are proving
to be the next generation design as opposed to the older, more
open, types of structures that rely on biologics for
osteosynthesis. In several patients, our lattice structures
have shown close to 90% boney in-growth after 6 months using no
biologics. We are excited to now offer these as patient specific
solutions."
The Company has seen over 1000 devices implanted since their
commercial launch in early 2017. The Company has
recently closed a Series B Round of $1M.
About Additive Orthopaedics, LLC.
Additive
Orthopaedics is an early stage orthopaedic company focused on the
integration of advanced manufacturing and biologics for the benefit
of a better patient outcome.
Contact:
Greg
Kowalczyk
732.882.6633
greg@additiveorthopaedics.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/additive-orthopaedics-announces-fda-clearance-of-their-patient-specific-3d-printed-bone-segments-for-the-global-extremities-market-300649830.html
SOURCE Additive Orthopaedics, LLC.